5 results
management empiric infectiousdiseases overview review acquired azithromycin cap clarithromycin community erythromycin flutycosine guidelines hap hcap hospitalacquiredpneumonia idsa macrolides outpatient regimen
Table 4. Recommended Initial Empiric Antibiotic Therapy for Hospital-Acquired Pneumonia (Non-Ventilator-Associated Pneumonia) #Management #InfectiousDiseases #Empiric #Antibiotics
Initial Empiric Antibiotic ... Hospital-Acquired Pneumonia ... Non-Ventilator-Associated Pneumonia ... #HAP #HCAP #HospitalAcquiredPneumonia ... #IDSA2016
Table 3. Suggested Empiric Treatment Options for Clinically Suspected Ventilator-Associated Pneumonia in Units Where Empiric Methicillin-Resistant
Ventilator-Associated Pneumonia ... InfectiousDiseases #Empiric #Antibiotics ... #VAP #VentilatorAssociatedPneumonia ... #IDSA2016
Outpatient Treatment of with Community-Acquired Pneumonia (CAP) No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Community-Acquired Pneumonia ... (CAP) No comorbidities ... Community #Acquired #Pneumonia ... #Antibiotics #Treatment ... Management #Guidelines #pharmacology
Flutycosine - Antibiotics Class Overview - Mechanism: 5-FC interferes with DNA and protein synthesis. Only
Flutycosine - Antibiotics ... Severe cryptococcal pneumonia ... #Pharmacology #Antibiotics ... #Flutycosine #Antifungal
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview 50S Ribosomal Inhibitor (PO and IV) Spectrum: Atypical organisms
Azithromycin - Antibiotics ... community-acquired pneumonia ... Ceftriaxone for CAP ... #Pharmacology #Antibiotics
No results found for "anion gap pneumonia pharmacology antibiotics antifungal idsa2016"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #anion #gap #pneumonia #pharmacology #antibiotics #antifungal #idsa2016